According to our (Global Info Research) latest study, the global HPV 9-valent Vaccine market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The HPV 9-valent vaccine, also known as the 9vHPV vaccine or Gardasil 9, is a vaccine used to protect against certain types of human papillomavirus (HPV).
This report is a detailed and comprehensive analysis for global HPV 9-valent Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global HPV 9-valent Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global HPV 9-valent Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global HPV 9-valent Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global HPV 9-valent Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for HPV 9-valent Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global HPV 9-valent Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck Group, GSK, Beijing Wantai, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
HPV 9-valent Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
HPV16
HPV18
Market segment by Application
9-16 Years Old
17-26 Years Old
27-45 Years Old
Major players covered
Merck Group
GSK
Beijing Wantai
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe HPV 9-valent Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of HPV 9-valent Vaccine, with price, sales quantity, revenue, and global market share of HPV 9-valent Vaccine from 2020 to 2025.
Chapter 3, the HPV 9-valent Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the HPV 9-valent Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and HPV 9-valent Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of HPV 9-valent Vaccine.
Chapter 14 and 15, to describe HPV 9-valent Vaccine sales channel, distributors, customers, research findings and conclusion.
- 1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global HPV 9-valent Vaccine Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 HPV16
- 1.3.3 HPV18
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global HPV 9-valent Vaccine Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 9-16 Years Old
- 1.4.3 17-26 Years Old
- 1.4.4 27-45 Years Old
- 1.5 Global HPV 9-valent Vaccine Market Size & Forecast
- 1.5.1 Global HPV 9-valent Vaccine Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global HPV 9-valent Vaccine Sales Quantity (2020-2031)
- 1.5.3 Global HPV 9-valent Vaccine Average Price (2020-2031)
- 2 Manufacturers Profiles
- 2.1 Merck Group
- 2.1.1 Merck Group Details
- 2.1.2 Merck Group Major Business
- 2.1.3 Merck Group HPV 9-valent Vaccine Product and Services
- 2.1.4 Merck Group HPV 9-valent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Merck Group Recent Developments/Updates
- 2.2 GSK
- 2.2.1 GSK Details
- 2.2.2 GSK Major Business
- 2.2.3 GSK HPV 9-valent Vaccine Product and Services
- 2.2.4 GSK HPV 9-valent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 GSK Recent Developments/Updates
- 2.3 Beijing Wantai
- 2.3.1 Beijing Wantai Details
- 2.3.2 Beijing Wantai Major Business
- 2.3.3 Beijing Wantai HPV 9-valent Vaccine Product and Services
- 2.3.4 Beijing Wantai HPV 9-valent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Beijing Wantai Recent Developments/Updates
- 3 Competitive Environment: HPV 9-valent Vaccine by Manufacturer
- 3.1 Global HPV 9-valent Vaccine Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global HPV 9-valent Vaccine Revenue by Manufacturer (2020-2025)
- 3.3 Global HPV 9-valent Vaccine Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of HPV 9-valent Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 HPV 9-valent Vaccine Manufacturer Market Share in 2024
- 3.4.3 Top 6 HPV 9-valent Vaccine Manufacturer Market Share in 2024
- 3.5 HPV 9-valent Vaccine Market: Overall Company Footprint Analysis
- 3.5.1 HPV 9-valent Vaccine Market: Region Footprint
- 3.5.2 HPV 9-valent Vaccine Market: Company Product Type Footprint
- 3.5.3 HPV 9-valent Vaccine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
- 4 Consumption Analysis by Region
- 4.1 Global HPV 9-valent Vaccine Market Size by Region
- 4.1.1 Global HPV 9-valent Vaccine Sales Quantity by Region (2020-2031)
- 4.1.2 Global HPV 9-valent Vaccine Consumption Value by Region (2020-2031)
- 4.1.3 Global HPV 9-valent Vaccine Average Price by Region (2020-2031)
- 4.2 North America HPV 9-valent Vaccine Consumption Value (2020-2031)
- 4.3 Europe HPV 9-valent Vaccine Consumption Value (2020-2031)
- 4.4 Asia-Pacific HPV 9-valent Vaccine Consumption Value (2020-2031)
- 4.5 South America HPV 9-valent Vaccine Consumption Value (2020-2031)
- 4.6 Middle East & Africa HPV 9-valent Vaccine Consumption Value (2020-2031)
- 5 Market Segment by Type
- 5.1 Global HPV 9-valent Vaccine Sales Quantity by Type (2020-2031)
- 5.2 Global HPV 9-valent Vaccine Consumption Value by Type (2020-2031)
- 5.3 Global HPV 9-valent Vaccine Average Price by Type (2020-2031)
- 6 Market Segment by Application
- 6.1 Global HPV 9-valent Vaccine Sales Quantity by Application (2020-2031)
- 6.2 Global HPV 9-valent Vaccine Consumption Value by Application (2020-2031)
- 6.3 Global HPV 9-valent Vaccine Average Price by Application (2020-2031)
- 7 North America
- 7.1 North America HPV 9-valent Vaccine Sales Quantity by Type (2020-2031)
- 7.2 North America HPV 9-valent Vaccine Sales Quantity by Application (2020-2031)
- 7.3 North America HPV 9-valent Vaccine Market Size by Country
- 7.3.1 North America HPV 9-valent Vaccine Sales Quantity by Country (2020-2031)
- 7.3.2 North America HPV 9-valent Vaccine Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
- 8 Europe
- 8.1 Europe HPV 9-valent Vaccine Sales Quantity by Type (2020-2031)
- 8.2 Europe HPV 9-valent Vaccine Sales Quantity by Application (2020-2031)
- 8.3 Europe HPV 9-valent Vaccine Market Size by Country
- 8.3.1 Europe HPV 9-valent Vaccine Sales Quantity by Country (2020-2031)
- 8.3.2 Europe HPV 9-valent Vaccine Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
- 9 Asia-Pacific
- 9.1 Asia-Pacific HPV 9-valent Vaccine Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific HPV 9-valent Vaccine Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific HPV 9-valent Vaccine Market Size by Region
- 9.3.1 Asia-Pacific HPV 9-valent Vaccine Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific HPV 9-valent Vaccine Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
- 10 South America
- 10.1 South America HPV 9-valent Vaccine Sales Quantity by Type (2020-2031)
- 10.2 South America HPV 9-valent Vaccine Sales Quantity by Application (2020-2031)
- 10.3 South America HPV 9-valent Vaccine Market Size by Country
- 10.3.1 South America HPV 9-valent Vaccine Sales Quantity by Country (2020-2031)
- 10.3.2 South America HPV 9-valent Vaccine Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
- 11 Middle East & Africa
- 11.1 Middle East & Africa HPV 9-valent Vaccine Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa HPV 9-valent Vaccine Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa HPV 9-valent Vaccine Market Size by Country
- 11.3.1 Middle East & Africa HPV 9-valent Vaccine Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa HPV 9-valent Vaccine Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
- 12 Market Dynamics
- 12.1 HPV 9-valent Vaccine Market Drivers
- 12.2 HPV 9-valent Vaccine Market Restraints
- 12.3 HPV 9-valent Vaccine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 13 Raw Material and Industry Chain
- 13.1 Raw Material of HPV 9-valent Vaccine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of HPV 9-valent Vaccine
- 13.3 HPV 9-valent Vaccine Production Process
- 13.4 Industry Value Chain Analysis
- 14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 HPV 9-valent Vaccine Typical Distributors
- 14.3 HPV 9-valent Vaccine Typical Customers
- 15 Research Findings and Conclusion
- 16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
- 16.3 Disclaimer
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook